WELLESLEY, Mass., March 10, 2006 -- Global technology company PerkinElmer Inc. announced it has acquired Agilix Corp.'s proprietary proteomics technology, a mass spectrometry-based approach used to determine changes in levels of proteins with a high degree of precision and without the use of analyte-specific reagents. Terms of the deal were not disclosed.
"PerkinElmer will use the intellectual property acquired from Agilix to develop a number of new technologies that will bring quantitative proteomics to a wider range of customers in drug discovery," said Robert F. Friel, president, PerkinElmer Life and Analytical Sciences. PerkinElmer also manufactures products and systems within two other business units, optoelectronics and fluid sciences.
Agilix, based in Woodbridge, Conn., has developed a labeling technology using isobaric mass tags that allows for the simultaneous quantification of molecules, such as proteins, from multiple samples. PerkinElmer says the technology enhances the utility of mass spectrometry, a preferred method for proteomic analysis.
For more information, visit: www.perkinelmer.com